Bradley Foster & Sargent Inc Abbott Laboratories Transaction History

Bradley Foster & Sargent Inc

$5.82 Billion
Q3 2024

A detailed history of Bradley Foster & Sargent Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Bradley Foster & Sargent Inc holds 600,330 shares of ABT stock, worth $69.5 Million. This represents 1.18% of its overall portfolio holdings.

Number of Shares

600,330

Previous 508,812 17.99%

Holding current value

$69.5 Million

Previous $52.9 Million 29.46%

% of portfolio

1.18%

Previous 0.97%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$100.07 - $118.13 $9.16 Million - $10.8 Million	91,518 Added 17.99%	600,330 $68.4 Million
Q2 2024 Aug 09, 2024	BUY	$100.73 - $112.44 $4.41 Million - $4.92 Million	43,764 Added 9.41%	508,812 $52.9 Million
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $1.37 Million - $1.52 Million	12,528 Added 2.77%	465,048 $52.9 Million
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $2.57 Million - $3.14 Million	28,459 Added 6.71%	452,520 $49.8 Million
Q2 2023 Aug 08, 2023	BUY	$100.78 - $112.29 $7.78 Million - $8.67 Million	77,222 Added 22.26%	424,061 $46.2 Million
Q1 2023 May 08, 2023	SELL	$96.86 - $114.01 $59,278 - $69,774	-612 Reduced 0.18%	346,839 $35.1 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $220,919 - $259,172	2,324 Added 0.67%	347,451 $38.2 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $166,620 - $192,915	-1,722 Reduced 0.5%	345,127 $33.4 Million
Q2 2022 Aug 11, 2022	SELL	$102.07 - $123.37 $318,458 - $384,914	-3,120 Reduced 0.89%	346,849 $37.7 Million
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $825,276 - $1.01 Million	7,238 Added 2.11%	349,969 $41.4 Million
Q4 2021 Mar 11, 2022	BUY	$115.53 - $141.46 $1.4 Million - $1.72 Million	12,155 Added 3.68%	342,731 $48.2 Million
Q3 2021 Nov 10, 2021	SELL	$116.66 - $129.06 $825,719 - $913,486	-7,078 Reduced 2.1%	330,576 $39.1 Million
Q2 2021 Aug 19, 2021	SELL	$105.79 - $124.53 $274,948 - $323,653	-2,599 Reduced 0.76%	337,654 $39.1 Million
Q1 2021 Apr 26, 2021	SELL	$108.84 - $128.23 $1.38 Million - $1.62 Million	-12,664 Reduced 3.59%	340,253 $40.8 Million
Q4 2020 Feb 11, 2021	SELL	$105.0 - $114.42 $17,220 - $18,764	-164 Reduced 0.05%	352,917 $38.6 Million
Q3 2020 Oct 26, 2020	SELL	$91.64 - $111.29 $815,596 - $990,481	-8,900 Reduced 2.46%	353,081 $38.4 Million
Q1 2020 May 07, 2020	SELL	$62.82 - $91.86 $157,426 - $230,201	-2,506 Reduced 0.69%	361,981 $28.6 Million
Q4 2019 Jan 29, 2020	SELL	$78.51 - $87.4 $180,415 - $200,845	-2,298 Reduced 0.63%	364,487 $31.7 Million
Q3 2019 Oct 30, 2019	SELL	$81.84 - $88.74 $319,912 - $346,884	-3,909 Reduced 1.05%	366,785 $30.7 Million
Q2 2019 Aug 08, 2019	SELL	$72.88 - $85.0 $466,723 - $544,340	-6,404 Reduced 1.7%	370,694 $31.2 Million
Q1 2019 May 02, 2019	SELL	$66.22 - $80.06 $287,924 - $348,100	-4,348 Reduced 1.14%	377,098 $30.1 Million
Q4 2018 Jan 30, 2019	SELL	$65.56 - $74.27 $867,489 - $982,740	-13,232 Reduced 3.35%	381,446 $27.6 Million
Q3 2018 Oct 31, 2018	SELL	$60.81 - $73.36 $1.56 Million - $1.89 Million	-25,716 Reduced 6.12%	394,678 $29 Million
Q2 2018 Jul 31, 2018	BUY	$57.57 - $63.54 $570,000 - $629,109	9,901 Added 2.41%	420,394 $25.6 Million
Q1 2018 May 07, 2018	SELL	$56.27 - $63.62 $679,966 - $768,784	-12,084 Reduced 2.86%	410,493 $24.6 Million
Q4 2017 Feb 06, 2018	SELL	$53.68 - $57.47 $349,456 - $374,129	-6,510 Reduced 1.52%	422,577 $24.1 Million
Q3 2017 Nov 03, 2017	BUY	$48.06 - $53.64 $20.6 Million - $23 Million	429,087	429,087 $22.9 Million

Others Institutions Holding ABT

# of Institutions

3,191

Shares Held

1.32B

Call Options Held

8.13M

Put Options Held

7.11M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bradley Foster & Sargent Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bradley Foster & Sargent Inc with notifications on news.

Account

Bradley Foster & Sargent Inc Abbott Laboratories Transaction History